Resumen
The SARS-CoV-2 coronavirus disease which emerged in 2019 (COVID-19), has forced the rapid development of vaccines to prevent the spread of infection and attempt to control the pandemic. Among the vaccines developed, one of the first to be approved with a new technology in the field of vaccination, was the mRNA (messenger ribonucleic acid) vaccine, with rates of effectiveness close to 95% for the prevention of severe COVID-19 disease. Common adverse events are mild local reactions, but there have been some reports of patients developing sub-acute thyroiditis and thyroid dysfunction after receiving the SARS-CoV-2 vaccine. This article presents two case reports of subacute thyroiditis shortly after receiving the COVID-19 vaccine.
Título traducido de la contribución | Subacute thyroiditis and thyrotoxicosis after SARS-CoV-2 vaccine: report of 2 cases |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 383-389 |
Número de páginas | 7 |
Publicación | Medicina y Laboratorio |
Volumen | 26 |
N.º | 4 |
DOI | |
Estado | Publicada - 2022 |
Publicado de forma externa | Sí |
Nota bibliográfica
Publisher Copyright:© 2022, Universidad de Antioquia. All rights reserved.
Palabras clave
- COVID-19
- adenovirus
- goiter
- messenger RNA
- thyroiditis
- vaccine